Patent ID: 6656459
Filing Date: 2003-12-02
Classification: A61K,A61P

Abstract:
A method for reducing inflammation, auto-immune response, and rejection of graft/implantation comprising administering an effective amount of at least one non-ionic block copolymer of the formula selected from the group consisting of F127 and L61 wherein, F127 has a molecular weight of 12600, an average number of oxypropylene units (n) of 65.2, an average number of oxyethylene units (m) of 200.4, and a hydrophilic-lipophilic balance of 22; and L61 has a molecular weight of 2000, an average number of oxypropylene units (n) of 31.0, an average number of oxyethylene units (m) of 4.5, and a hydrophilic-lipophilic balance of 3.